Hypertension  >>  AZD4017  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD4017 / AstraZeneca
NCT02017444 / 2013-003643-31: Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.

Completed
2
31
Europe
AZD4017, 11b-Hydroxysteroid dehydrogenase type 1 inhibitor, Placebo
University of Birmingham
Idiopathic Intracranial Hypertension
12/16
12/16

Download Options